Executive Board members Sabine Eckhardt, Dr. Gunnar Wiedenfels and Dr. Ralf Schremper also have PSUs from work performed before they joined the Executive Board. These were not granted as remuneration for their role on the Executive Board and are thus not included in the overview.

To settle incentives for work performed before joining the Executive Board, Christof Wahl was allocated a one-off additional amount of 24,000 PSUs in the financial year 2016.

Dr. Christian Wegner left the Executive Board effective December 31, 2016. Information on share-based compensation instruments in his case can be found in the chapter regarding total compensation of former members of the Executive Board.

Nominal amounts of PSUs when granted.

Dr. Gunnar Wiedenfels left the Executive Board as of March 31, 2017, Dr. Ralf Schremper as of July 31, 2017, and Thomas Ebeling will leave as of February 22, 2018. For information on the effects on the Group Share Plan, please refer to “Notes on the Compensation of Departed or Departing Executive Board Members.

The total cost in the financial year 2017 includes an adjustment of the conversion factor for the performance share units granted (100.1%) for the Group Share Plan 2014 and was measured as of December 31, 2017. No adjustments were made due to anti-dilution protection or an individual increase by the Supervisory Board. The total cost for Dr. Ralf Schremper is negative due to declines in the share price in the financial year 2017. The total cost in the financial year 2016 includes an adjustment of the conversion factor for the performance share units granted (107.6%) for the Group Share Plan 2013 and was measured as of December 31, 2016.